☰

Sandy Der - Publications

Affiliations: 
Laboratory Medicine and Pathobiology University of Toronto, Toronto, ON, Canada 
Area:
Molecular Biology, Medicine and Surgery, Immunology, Genetics, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Der S, Zhu CQ, Brower S, Uihlein A. Predicting Prognosis of Early-Stage Non-Small Cell Lung Cancer Using the GeneFx® Lung Signature. Plos Currents. 7. PMID 26558161 DOI: 10.1371/Currents.Eogt.49Eb4408C48237B8A8D4Ed2060951083  0.351
2014 Wong KM, Qiu X, Cheng D, Azad AK, Habbous S, Palepu P, Mirshams M, Patel D, Chen Z, Roberts H, Knox J, Marquez S, Wong R, Darling G, Waldron J, ... ... Der S, et al. Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Cancer Medicine. 3: 426-33. PMID 24519853 DOI: 10.1002/Cam4.201  0.327
2014 Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao MS. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 59-64. PMID 24305008 DOI: 10.1097/Jto.0000000000000042  0.306
2013 Cuffe S, Cheng L, Azad AK, Brhane Y, Cheng D, Chen Z, Qiu X, Boyd K, Emami M, Leighl NB, Der S, Xu W, Shepherd FA, Tsao MS, Reisman D, et al. Effect of BRM promoter variants on survival outcomes of stage III-IV non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 31: 11057-11057. DOI: 10.1200/Jco.2013.31.15_Suppl.11057  0.351
2012 Wong KM, Qiu X, Cheng D, Azad AK, Palepu PR, Mirshams M, Patel D, Chen Z, Roberts H, Knox JJ, Wong R, Darling GE, Waldron JN, Goldstein DP, Leighl NB, ... ... Der S, et al. The effect of two BRM promoter variants on the risk of stage I/II upper aerodigestive tract cancers. Journal of Clinical Oncology. 30: 10522-10522. DOI: 10.1200/Jco.2012.30.15_Suppl.10522  0.359
2012 To C, Strumpf D, Panchal D, Li M, Pham N, Xie W, Yanagawa N, Bandarchi B, Chui MH, Der S, Shepherd FA, Kislinger T, Moran M, Jurisica I, Muthuswamy L, et al. Abstract 5069: Genomic profiles of primary non-small cell lung cancer (NSCLC) xenograft tumors identify distinct gene signatures associated with histological subtypes Cancer Research. 72: 5069-5069. DOI: 10.1158/1538-7445.Am2012-5069  0.433
2011 Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, Der S, Shepherd FA, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 7160-5. PMID 21474781 DOI: 10.1073/Pnas.1014506108  0.436
2011 Hai J, Zhu C, Der S, Jurisica I, Tsao M. Abstract 1404: L1CAM in non-small-cell lung carcinoma Cancer Research. 71: 1404-1404. DOI: 10.1158/1538-7445.Am2011-1404  0.433
2010 Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4417-24. PMID 20823422 DOI: 10.1200/Jco.2009.26.4325  0.387
2009 Zhu CQ, Pintilie M, John T, Strumpf D, Shepherd FA, Der SD, Jurisica I, Tsao MS. Understanding prognostic gene expression signatures in lung cancer. Clinical Lung Cancer. 10: 331-40. PMID 19808191 DOI: 10.3816/Clc.2009.N.045  0.302
2009 Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, Der SD, Tsao MS, Penn LZ, Jurisica I. Prognostic gene signatures for non-small-cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 2824-8. PMID 19196983 DOI: 10.1073/Pnas.0809444106  0.312
2008 Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, Lee V, Jin H, Wang M, Der S, Lightfoot J, Wright JA, Young AH. Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunology, Immunotherapy : Cii. 57: 1757-69. PMID 18351336 DOI: 10.1200/Jco.2005.23.16_Suppl.2537  0.361
2007 Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, Strumpf D, Johnston MR, Darling G, Keshavjee S, Waddell TK, Liu N, Lau D, Penn LZ, Shepherd FA, Jurisica I, ... Der SD, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5562-9. PMID 18065728 DOI: 10.1200/Jco.2007.12.0352  0.32
2007 Li H, Cao MY, Lee Y, Benatar T, Lee V, Feng N, Gu X, Liu P, Jin H, Wang M, Der S, Lightfoot J, Wright JA, Young AH. Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo. International Immunopharmacology. 7: 1350-9. PMID 17673150 DOI: 10.1016/J.Intimp.2007.06.001  0.398
2007 James JM, Yun J, Der S, Rana S. Microarray Analysis of Human Vascular Smooth Muscle Cell Responses to Bacterial Lipopolysaccharide American Journal of Immunology. 3: 56-73. DOI: 10.3844/Ajisp.2007.56.73  0.361
2006 Andrade CF, Kaneda H, Der S, Tsang M, Lodyga M, Chimisso Dos Santos C, Keshavjee S, Liu M. Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 25: 1317-23. PMID 17097495 DOI: 10.1016/J.Healun.2006.09.017  0.38
2005 Ni Z, Karaskov E, Yu T, Callaghan SM, Der S, Park DS, Xu Z, Pattenden SG, Bremner R. Apical role for BRG1 in cytokine-induced promoter assembly. Proceedings of the National Academy of Sciences of the United States of America. 102: 14611-6. PMID 16195385 DOI: 10.1073/Pnas.0503070102  0.315
2005 Li H, Cao MY, Lee Y, Lee V, Feng N, Benatar T, Jin H, Wang M, Der S, Wright JA, Young AH. Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages. Cancer Immunology, Immunotherapy : Cii. 54: 1115-26. PMID 15891881 DOI: 10.1007/S00262-005-0698-X  0.378
2005 Begum S, Emami N, Emani N, Cheung A, Wilkins O, Der S, Hamel PA. Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR. Oncogene. 24: 1860-72. PMID 15688035 DOI: 10.1038/Sj.Onc.1208315  0.37
2004 Andrade CF, Kaneda H, Der S, Tsang M, Santos CC, Keshavjee S, Liu M. Alterations in gene expression of toll-like receptors in human lung transplantation Journal of Heart and Lung Transplantation. 23. DOI: 10.1016/J.Healun.2003.11.272  0.321
2003 Suzuki N, Suzuki S, Eriksson U, Hara H, Mirtosis C, Chen NJ, Wada T, Bouchard D, Hwang I, Takeda K, Fujita T, Der S, Penninger JM, Akira S, Saito T, et al. IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. Journal of Immunology (Baltimore, Md. : 1950). 171: 6065-71. PMID 14634120 DOI: 10.4049/Jimmunol.171.11.6065  0.335
2001 Veer MJd, Holko M, Frevel MAE, Walker E, Der S, Paranjape JM, Silverman RH, Williams BRG. Functional classification of interferon-stimulated genes identified using microarrays Journal of Leukocyte Biology. 69: 912-920. DOI: 10.1189/Jlb.69.6.912  0.344
1997 Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams BR. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. The Embo Journal. 16: 406-16. PMID 9029159 DOI: 10.1093/Emboj/16.2.406  0.324
Show low-probability matches.